Anetumab ravtansine | Antibody-Drug Conjugate inhibitor | Read Reviews & Product Use Citations

Anetumab ravtansine (BAY 94-9343) is an antibody-drug conjugate (ADC) composed of a human anti-mesothelin antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. Anetumab ravtansine has the potential to treat advanced solid tumors.

CAS No. 1375258-01-7

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.72mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Antibody-Drug Conjugate Inhibitors

Biological Activity

Description	Anetumab ravtansine (BAY 94-9343) is an antibody-drug conjugate (ADC) composed of a human anti-mesothelin antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. Anetumab ravtansine has the potential to treat advanced solid tumors.

References
[1] Golfier S, et al. Mol Cancer Ther (2014) 13 (6): 1537–1548.

References

[1] Golfier S, et al. Mol Cancer Ther (2014) 13 (6): 1537–1548.

Product Details

CAS No.	1375258-01-7
ADC antiody	Anetumab
ADC cytotoxin	DM4
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field